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Abstract
Background. Diagnosing acute kidney injury (AKI) in preterm newborns, who are particularly susceptible 
to renal damage, is a serious challenge as there is no definite consensus about the diagnostic criteria.
Objectives. The objective of this study was to measure the values for selected urinary biomarkers and 
estimated glomerular filtration rate (eGFR) among a population of preterm infants with uncomplicated 
clinical course as well as to determine whether these markers depend on birth weight (BW), gestational 
age (GA), postnatal age (PNA), or gender.
Material and methods. The prospective study was carried out in neonatal intensive care unit (NICU). 
The evaluation included 57 children that were divided into 3 categories according to BW: low birth weight 
(LBW) – 1501–2500 g (22 infants); very low birth weight (VLBW) – 1000–1500 g (25 infants); and extremely 
low birth weight (ELBW) – 750–999 g (10 infants). Urine samples were collected daily between the 4th 
and 28th day of life for measurements of creatinine (Cr), neutrophil gelatinase-associated lipocalin (NGAL), 
osteopontin (OPN), and human kidney injury molecule 1 (hKIM1).
Results. The values of the 3 urine tubular biomarkers, serum creatinine and eGFR were taken in substantially 
healthy preterm infants with normal kidney function at 4 time intervals during the neonatal period. Their 
correlations were determined and a multivariable regression analysis was carried out with respect to BW, 
GA, PNA, and gender. Trends of the studied markers in terms of PNA and BW were also assessed with 
the Jonckheere–Terpstra test.
Conclusions. Glomerular and tubular function in preterm neonates during the 1st month of life is significantly 
influenced by BW, GA, PNA, and gender.
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Introduction
Worldwide, approx. 6–10% of infants are born preterm. 
Preterm neonates are particularly susceptible to  renal 
damage, as they are born before week 36 of gestation, when 
the complex process of nephrogenesis is still incomplete.1,2
Diagnosing acute kidney injury (AKI) in preterm new-
borns is a serious challenge because there is no definite 
consensus about the diagnostic criteria. Its true incidence 
among this age group is actually unknown, but the risk for 
this complication is considerably higher in more immature 
neonates.3,4 Generally, AKI occurs in as many as 56% of ne-
onates treated in neonatal intensive care units (NICU),5 
while the mortality rate among this population with AKI 
ranges from 33% to 78%.6
The search for new AKI markers is based on the poor 
prognosis of AKI in newborns, which is partially caused 
by the delay in diagnosis and therapeutic intervention. 
Diagnosis made only on the basis of serum creatinine (SCr) 
level in this specific population is made more complicated 
by several factors, including birth weight (BW), gestational 
(GA) and postnatal age (PNA), functional tubular imma-
turity, low glomerular filtration rate (GFR), high renal vas-
cular resistance, high plasma renin activity, and decreased 
intercortical perfusion.7,8 Furthermore, SCr is a measure 
of glomerular function – not of kidney damage.9
Advances in the field of clinical proteomics have greatly 
accelerated the discovery of novel urinary proteins which 
promptly increase in response to renal tubular injury.10 
Urine AKI biomarkers include neutrophil gelatinase-as-
sociated lipocalin (NGAL),11 human kidney injury mol-
ecule 1 (hKIM1)12,13 and osteopontin (OPN),14 among many 
others. Plasma NGAL is freely filtered by the glomerulus 
and then largely reabsorbed by proximal tubular cells 
captured by megalin; thus, very little (0.1–0.2%) is found 
in  the urine.15 With renal tubular injury, NGAL reab-
sorption may be decreased, whereas its de novo synthesis 
in the epithelial cells of the loop of Henle and of distal 
tubule segments is  strongly upregulated, after which 
it is found in high concentrations in the urine.16 Neutrophil 
gelatinase-associated lipocalin has also been shown to play 
an important role in kidney development.17 Osteopontin 
in the kidney is mainly found in the loop of Henle and 
distal nephrons, can be upregulated in all tubular and glo-
merular segments following kidney damage and may play 
a role in renal repair.18 Human kidney injury molecule 1 
is expressed in low levels in healthy proximal tubule cells; 
in case of kidney ischemia or toxicity, it is highly upregu-
lated and shed into the extracellular space and the urine.19
According to the literature, these biomarkers are not 
only more sensitive than SCr for identifying AKI, but 
they can also indicate damage in a specific tubular re-
gion of the nephron.20 Additionally, the ability to assay 
the markers noninvasively in the urine represents a sig-
nificant advantage over current methods, especially for 
the neonatal population.21 Still, despite the promising role 
of these novel urinary biomarkers in the early detection 
of AKI, a reference range for the preterm neonatal popula-
tion has not yet been fully established. The inability of im-
mature tubules to fully reabsorb these proteins in preterm 
infants may also lead to varying values in this heterogenic 
population.8 Hence, the primary objective of this study 
was to determine the values for selected urinary tubular 
biomarkers in a population of preterm infants who have 
relatively uncomplicated clinical courses, and to determine 
whether these markers depend on BW, GA, PNA, or gen-
der. To evaluate and characterize the glomerular function 
of the studied group, the estimated GFR (eGFR) values 
were calculated with the equation developed by Schwartz 
et al.,22 which is easy to use bedside.
Material and methods
The prospective, observational study was carried out 
in the Neonatal Intensive Care Unit of the Department 
of Pediatrics at Jagiellonian University College of Medi-
cine in Kraków, Poland. Prospective observations spanned 
the  period from September 2010 to  September 2012. 
The investigation was approved by the local Bioethical 
Committee (approval No. KBET/64/B/2009).
The inclusion criteria were as follows: informed con-
sent of the parents (or legal guardians) and an age of up 
to 48 h upon the child’s admission to the NICU. Ultimately, 
in the final analysis of data, only NICU survivors were 
included. The exclusion criteria consisted of a lack of in-
formed consent, prenatal maternal angiotensin-converting 
enzyme (ACE) inhibitor or indomethacin therapy, congeni-
tal anomalies of the kidney and urinary tract (CAKUT), 
chromosomal aberrations, other severe, complex anoma-
lies affecting an unfavorable late prognosis and complica-
tions such as acute renal failure, sepsis, suspicion of sepsis, 
urinary tract infection, tension pneumothorax, necrotizing 
enterocolitis, grade 3 and 4 intracranial hemorrhage, pat-
ent ductus arteriosus (PDA) requiring treatment, therapy 
with nonsteroidal anti-inflammatory drugs or amphoteri-
cin, or any type of surgery during the entire observation 
period.
The presence of AKI in a given child was determined 
based on the neonatal/pediatric (n/p) RIFLE and AKIN 
scales.5,23 Serum creatinine was assessed at  least every 
48–72 h and whenever it seemed necessary. The normal 
ranges of SCr used for the studied population were taken 
from the study of Bateman et al.24, while the eGFR values 
were calculated according to the one-marker equation de-
veloped by Schwartz et al.22 The presence of sepsis in a given 
child was determined based on the gold standard, which 
continues to  be a  positive result of  blood bacteriology, 
while a suspicion of sepsis was based on such clinical and 
laboratory criteria as apnea or deterioration of mechanical 
ventilation parameters, abnormalities of peripheral perfu-
sion, abnormalities of arterial pressure, hepatomegaly and/
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or splenomegaly, signs of feeding intolerance, leucopenia 
(<4,000/mL) or elevated white blood cell count (>10,000/mL), 
thrombocytopenia (<100,000/mL), immature granulocyte 
count (immature neutrophils/total neutrophils) >0.2, and 
elevated C-reactive protein (CRP) (>10 mg/L).
In the calculation process of the final results for urinary 
markers, only data from days without aminoglicoside (AG) 
administration, injury or 2nd stage of AKI according to the 
n/pRIFLE and AKIN scale, respectively, or signs or symp-
toms of sepsis were taken into consideration. The only AG 
used in our NICU was amikacin. The antibiotic was dosed 
under close serum level monitoring. Respiratory failure (RF) 
was recognized when the implementation of synchronized 
intermittent mandatory ventilation (SIMV) or continuous 
positive airway pressure (CPAP) was warranted. Neverthe-
less, in view of the fact that very low birth weight (VLBW) 
and extremely low birth weight (ELBW) children very often 
require respiratory support, either SIMV or CPAP, it was 
not considered an exclusion criterion.
Clinical observations were performed over the  first 
28 days of life (DOL). Urinary concentrations of the mark-
ers being studied were measured on a daily basis between 
the 4th and 28th DOL (25 days). A urine sample for creati-
nine (uCr), NGAL (uNGAL), OPN (uOPN), and hKIM1 
assays was collected according to  the  schedule, once 
a day (at 7.00 a.m.) using a urine bag or a catheter. None 
of the children were specially catheterized to meet the pur-
pose of the investigation; the insertion of a urinary cath-
eter was dictated by the clinical status of the child. In or-
der to obtain an appropriate volume of urine, in the case 
of  catheterized children, the urine bags were emptied 
approx. 1 h prior to the planned urine collection, while 
in case of children without urinary catheters, a urine bag 
was fixed approx. 1 h before the planned urine collection. 
The values of the markers were analyzed in 4 time inter-
vals: 4–7, 8–14, 15–21, and 22–28 DOL.
Description of laboratory methods
The collected urine was centrifuged and frozen at −80°C. 
Laboratory measurements of SCr and uCr were performed 
using the enzymatic method with a VITROS FS system 
(Ortho Clinical Diagnostics, Raritan, USA). The reading 
and recording of the results were automatic. The meth-
ods of analysis remained unchanged throughout the study 
period. Measurements of NGAL were performed employ-
ing a Human Lipocalin – 2/NGAL ELISA RD 191102200R 
kit (BioVendor, Brno, Czech Republic) and the immuno-
enzymatic method (enzyme-linked immunosorbent assay 
(ELISA)). The kit had the following parameters: intra-kit 
precision CV – 7.7%; inter-kit precision CV – 9.8%; and 
sensitivity of the method – <0.02 ng/mL. Determination 
of OPN was carried out using the Human Osteopontin 
Elisa BBT0482R kit (BioVendor) and the immunoenzymatic 
method (ELISA). The kit had the following parameters: in-
tra-kit method precision CV – 3.7%; inter-kit precision CV 
– 5.8%; sensitivity of the method – <50 pg/mL; measure-
ment range – 156–10,000 pg/mL. Measurements of human 
Kidney Injury Molecule-1 (hKIM1) were performed with 
an Elisa Kit for Human Kidney Injury Molecule 1 (Kim1) 
E0785HU kit (USCN Life Science Inc., Wuhan, China) and 
the immunoenzymatic method (ELISA). The kit had the fol-
lowing parameters: intra-kit method precision CV – <10%; 
inter-kit precision CV – <12%; sensitivity of the method 
–  <0.038  ng/mL; and measurement range –  0.156–
10 ng/mL. Sample absorbance was measured by the sin-
gle-wave method using a 450-nm filter and the Universal 
Microplate Reader Elx800NB automatic microplate reader 
(BIO-TEK Instruments, Inc, Winooski, USA). Correction 
of urinary biomarker measurements with urine creatinine 
was performed to account for urine concentration.
Predefined comparisons
The children were divided into 3 categories according 
to their BW: low birth weight (LBW) infants with a BW 
of 1,501–2,500 g; VLBW infants with a BW of 1,000–
1,500 g; and ELBW infants with a BW of 750–999 g.
Statistical methods
The following tests were used, as deemed appropriate: Kol-
mogorov–Smirnov test (KS), Student’s t-test, rank sum Wil-
coxon test, and Fisher’s exact test. For normally distributed 
variables, the mean and standard deviation (SD) were calcu-
lated; otherwise, the median and interquartile range (IQR) 
range are presented. The significance level was 0.05 for all 
tests, apart from the KS test, where it was set to 0.1 in order 
to make it more restrictive for the null hypothesis. The val-
ues of the studied markers were preliminarily calculated 
by the common logarithm, as in the papers listed in Refer-
ences10,17,25; zero values – accounting for 10.8% of the results 
– were rejected. In this way, the log-norm distribution was 
achieved for all of the groups, as confirmed by the KS test. 
Having determined the parameters of the Gaussian model 
for the log-norm data, the authors defined 50% confidence 
intervals (CI50%), which – in the case of a Gaussian distribu-
tion – are equivalent to IQR. Subsequently, the mean values 
of the log-norm distributions and the CI50% range limits 
were converted to original values of the markers, thus arriv-
ing at respective geometric means and CI50% range limits. 
Statistical comparisons of data groups analyzed in this way 
were performed using Student’s t-test for the logarithmic 
values. For the above values of the markers, the authors 
analyzed possible correlations with BBW, GA and DOL, 
also grouping by gender, and carried out a multivariable 
regression analysis in order to determine their dependence 
on the abovementioned variables. The Jonckheere–Terps-
tra test, a rank-based nonparametric test, was used to de-
termine if there is a statistically significant trend between 
the ordinal independent variables (calendar-day intervals 
(4–7, 8–14, 15–21 and 22–28 DOL) and BW groups (ELBW, 
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VLBW and LBW)) and the continuous dependent variables: 
eGFR, SCr, uNGAL, uOPN, and hKIM1 concentrations. 
The STATISTICA v. 12.0 (StatSoft, Inc., Tulsa, USA) and 
MATLAB v. 2015a (Mathworks, Natick, USA) packages were 
used for all computations and to create the graphs.
Results
Fifty-seven infants were included in the study: 22 LBW, 25 
VLBW and 10 ELBW newborns. All of the infants were of Cau-
casian race. The main diagnoses at admission in the LBW 
group were respiratory disorders (of various severity and 
origin) (n = 14) and prematurity (n = 8); in the VLBW group, 
it was respiratory disorders (of various severity and origin) 
(n = 6) and prematurity and severe prematurity (n = 19); and 
in the ELBW group, the diagnosis was severe prematurity 
with respiratory disorders (n = 10). None of the children en-
rolled in the study died during their NICU stay.
As shown in Table 1, which presents a clinical summary 
of the investigated population, the analyzed groups of chil-
dren were comparable with respect to gender, delivery meth-
ods, fetal maturity, Apgar score, urine output (UO), and 
AG use. The infants from all study groups were generally 
in a good and stable condition throughout the entire ob-
servation period, as confirmed by their Score for Neonatal 
Acute Physiology II (SNAP II), which practically did not 
exceed the mean value of 5 points in any of the analyzed 
subgroups (a fact which predicts a good prognosis in a neo-
nate) and showed no significant differences among the sub-
groups.26 Similarly, the mean arterial pressure (MAP) values 
of the studied patient populations were within normal limits 
for their GA, at approx. the 50th percentile.27
Fig. 1. Serum creatinine distribution parameters: mean ±SD, calculated 
from data collected in 4 weekly intervals in the study population
Table 1. Clinical summary of the study population (n = 57)
Variable





Number (%) Number (%) Number (%) p-value for Fisher’s exact test
Females/males 10 (45%)/12 (55%) 15 (60%)/10 (40%) 5 (50%)/5 (50%) NS NS NS
Cesarean delivery 20 (91%) 19 (76%) 10 (100%) NS NS NS
SGA/AGA 3 (14%) 1 (4%) 1 (10%) NS NS NS
PDA 7 (31.8%) 8 (32%) 4 (40%) NS NS NS
RF 11 (50%) 19 (76%) 9 (90%) NS 0.0469 NS
AG 2 (9.1%) 8 (32%) 2 (20%) NS NS NS
Mean (SD) Mean (SD) Mean (SD) p-value for Student t-test
GA [weeks] 32.4 (2.1) 29.2 (1.7) 28.0 (2.4) 0.000 0.000 NS
BW [g] 1710.2 (166.2) 1244.8 (161.0) 947.5 (53.8) 0.000 0.000 0.000
Birth body length [cm] 43.4 (1.9) 38.9 (2.5) 36.6 (1.6) 0.000 0.000 0.011
Median (IQR) Median (IQR) Median (IQR) p-value for Wilcoxon test
Apgar score 3/5 8 (2.0) 7 (4.0) 6.5 (2.0) NS NS NS
SNAP II 5.0 (0.0) 5.0 (0.0) 5.0 (5.0) NS NS NS
RF – number of days 2.0 (5.3) 4.0 (17.3) 24.0 (4.3) NS 0.000 0.015
MAP [mm Hg] 49.7 (13.0) 46.0 (12.3) 44.3 (12.3) 0.000 0.000 0.008
AG administration 
– number of days 
4.0 (2.0) 4.5 (4.00) NS NS NS
UO [mL/kg/h] 2.9 (0.9) 3.1 (1.0) 2.9 (1.3) NS NS NS
NICU hospitalization [days] 27.5 (16.0) 45.0 (24.8) 63.0 (21.0) 0.000 0.000 NS
RF – respiratory failure (number of days of CPAP and SIMV administration); AG – number of days of AG administration within the group that received 
an antibiotic; SL – spontaneous labor; CS – cesarean  section; MAP – mean arterial pressure; UO – urinary output; SGA – small for gestational age; 
AGA – appropriate for gestational age; BW – body weight; LBW – low body weight; VLBW – very low body weight; ELBW – extremely low body weight; 
NICU – neonatal intensive care unit; SD – standard deviation.
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The number of days when a urine sample could poten-
tially be collected was as follows: in the LBW group – 429; 
in the VLBW group – 623; and in the ELBW group – 251 
(in total: 1,303 days). The final number of days included 
in the analysis – once days affected by the above inter-
fering factors were excluded – was 1,126 (86.4%), with 
the following values for the selected population groups: 
LBW – 374 (87.2%), VLBW – 538 (86.4%) and ELBW – 214 
(85.3%).
Fig. 2. Estimated glomerular filtration rate (eGFR) distribution parameters: 
mean ±SD, calculated from data collected in 4 weekly intervals 
in the study population
Table 2. Serum creatinine (SCr) and estimated glomerular filtration rate 
(eGFR) distribution parameters calculated from data collected in 4 weekly 
intervals in the studied population; data is presented as mean (standard 










LBW 61.1 (13.3) 50.1 (10.7) 44.9 (6.8) 34.3 (5.4) 0.000
VLBW 61.0 (14.6) 54.0 (14.3) 42.9 (10.3) 39.3 (8.7) 0.01
ELBW 65.8 (15.0) 59.0 (13.5) 48.9 (11.6) 43.2 (9.1) 0.02
p-value 0.05 0.03 NS 0.01
eGFR [mL/min/1.73 m2]
LBW 27.4 (7.1) 33.9 (9.70) 36.8 (5.3) 48.2 (7.9) 0.000
VLBW 24.6 (5.5) 28.4 (7.1) 36.4 (9.6) 39.6 (9.2) 0.003
ELBW 21.3 (6.1) 24.7 (7.9) 29.8 (8.9) 33.9 (9.7) 0.03
p-value 0.01 0.02 0.05 0.005
DOL – days of life; LBW – low body weight; VLBW – very low body weight; 
ELBW – extremely low body weight.
Table 3. Geometric mean and CI50% of uNGAL values calculated from data collected in 4 weekly intervals in the study groups; p-values were computed for 
the Jonckheere–Terpstra test for ordered alternatives
Variable 4–7 DOL 8–14 DOL 15–21 DOL 22–28 DOL p-value
Females
NGAL [ng/mL]
LBW 11.1 (4.7–25.9) 6.7 (2.9–15.5) 4.7 (1.6–14.3) 15.8 (6.7–37.0) NS
VLBW 24.0 (10.2–56.6) 14.3 (5.1–40.2) 11.2 (4.2–29.8) 9.4 (4.1–21.7) <0.001
ELBW 19.3 (8.9–41.9) 15.2 (7.1–32.5) 12.4 (6.9–22.3) 18.5 912.5–27.3) NS
p-value 0.02 0.01 0.02 NS –
NGAL [ng/mgCr]
LBW 69.7 (33.0–147.2) 46.9 (20.4–107.8) 36.8 (11.1–122.4) 120.7 (52.6–276.8) NS
VLBW 217.1 (89.9–524.2) 120.0 (40.4–356.3) 89.4 (32.2–247.6) 78.7 (30.9–200.6) <0.001
ELBW 173.3 (62.9–477.4) 116.7 (44.3–307.6) 94.0 (46.8–188.8) 155.4 (83.9–287.8) NS
p-value 0.05 0.03 0.01 NS –
Males
NGAL [ng/mL]
LBW 5.5 (2.3–13.10) 3.1 (1.2–8.0) 3.3 (1.1–10.1) 1.8 (0.9–3.5) 0.01
VLBW 14.7 (6.3–34.3) 9.0 (2.5–32.0) 5.8 (1.7–19.2) 3.9 (1.1–14.2) <0.001
ELBW 23.0 (12.0–44.0) 23.6 (8.2–67.7) 8.7 (3.4–21.7) 7.5 (2.9–19.7) 0.03
p-value <0.001 <0.001 0.02 0.01 –
NGAL [ng/mgCr]
LBW 36.8 (15.4–87.8) 22.3 (8.3–59.9) 22.6 (7.7–66.8) 9.7 (4.6–20.4) 0.01
VLBW 110.7 (45.0–272.2) 81.2 (23.9–276.1) 51.0 (15.3–170.1) 33.1 (9.6–114.2) <0.001
ELBW 208.6 (113.3–384.0) 172.7 (60.3–494.1) 78.1 (33.5–182.3) 65.4 (25.6–166.9) 0.02
p-value <0.001 <0.001 0.01 0.003 –
DOL – days of life; LBW – low body weight; VLBW – very low body weight; ELBW – extremely low body weight; NGAL – neutrophil gelatinase-associated 
lipocalin; uNGAL – urine neutrophil gelatinase-associated lipocalin.
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Table 2 and Fig. 1 and 2 present the values of SCr and 
eGFR calculated for the study groups. As it follows from 
the data and the Jonckheere–Terpstra test results for or-
dered alternatives, there is a statistically significant trend 
of  lower SCr values and higher eGFR values in all BW 
groups with respect to PNA; simultaneously, there is a sig-
nificant trend of higher SCr values and lower eGFR values 
with respect to lower BW (except for SCr values in the 3rd 
time interval).
Table 3 presents the geometric means and CI50% for 
the values of uNGAL, separated by gender, that were found 
in the 4 time intervals in the groups of children. As it fol-
lows from the data and the Jonckheere–Terpstra test results 
for ordered alternatives, there is a statistically significant 
trend of lower uNGAL values with respect to PNA (except 
LBW and ELBW females); likewise, there is a significant 
trend of higher uNGAL values with respect to lower BW 
(except for females in the 4th time interval). The analy-
sis of logarithmic correlations of the uNGAL values per-
formed both in girls and in boys demonstrated negative, 
average and high coefficients (R: −0.4–−0.7; Table 6) for all 
of the uNGAL values, with respect to both BW and GA. 
Similarly, the analysis of the results of the multivariable lin-
ear regression for logarithmic uNGAL values with respect 
to BW, GA, PNA, and gender demonstrated a significant 
effect from all of these factors on the uNGAL values: they 
decreased by the percentage given in Table 7 with BW 
increasing by 100 g and GA increasing by 1 week and each 
subsequent DOL. Moreover, it was shown that the values 
of this marker were significantly (approx. by 40%) higher 
in girls than in boys (Table 7).
Table 4 presents the geometric means and CI50% for 
the values of uOPN, broken by gender, that were recorded 
in the study groups at the 4 time intervals. As it follows 
from the data and the Jonckheere–Terpstra test results for 
ordered alternatives, there is no trend of uOPN values with 
respect to PNA; however, there is a significant trend of high-
er uOPN values correlating with lower BW. The analysis 
of logarithmic correlations of the uOPN values showed neg-
ative, average and high coefficients (R: −0.4–−0.7; Table 6) 
for most of the values with respect to BW and GA. There 
were no such correlations for the absolute uOPN correlation 
in girls with respect to GA or uOPN/mgCr in boys with 
respect to BW and GA. In turn, the analysis of the results 
of the multivariable linear regression for logarithmic uOPN 
values performed solely with respect to BW and gender 
showed a significant effect of these factors (the marker val-
ues were significantly higher – by approx. 40% – in boys 
than in girls); no significant effect of GA or PNA was ob-
served on the uOPN values (Table 7).
Table 4. Geometric mean and CI50% of uOPN values calculated from data collected in 4 weekly intervals in the study groups; p-values were computed for 
the Jonckheere–Terpstra test for ordered alternatives
Variable 4–7 DOL 8–14 DOL 15–21 DOL 22–28 DOL p-value
Females
OPN [ng/mL]
LBW 79.1 (36.8–170.2) 74.4 (32.2–172.0) 56.3 (19.4–163.3) 76.8 (31.6–186.4) NS
VLBW 166.6 (77.9–356.20) 145.6 (57.8–366.3) 109.2 (34.1–349.80 164.6 (71.1–380.8) NS
ELBW 180.5 (99.4–327.8) 139.8 (62.8–311.5) 149.6 (73.5–304.5) 173.1 (56.0–534.8) NS
p-value 0.02 0.04 0.02 0.05 –
OPN [ng/mgCr]
LBW 493.4 (234.4–1038.4) 527.3 (231.2–1202.6) 478.8 (174.2–1316.3) 665.4 (259.9–1703.7) NS
VLBW 1478.9 (699.5–3126.8) 1158.3 (469.6–2857.1) 860.3 (297.4–2488.4) 1377.4 (610.4–3108.4) NS
ELBW 1620.4 (662.7–3962.2) 1137.3 (489.2–2644.2) 1326.6 (720.7–2441.7) 1604.6 (752.3–3422.7) NS
p-value 0.05 0.03 0.01 0.03 –
Males
OPN [ng/mL]
LBW 126.4 (73.8–216.5) 99.1 (44.8–219.3) 103.9 (36.0–299.6) 79.3 (19.5–323.3) NS
VLBW 227.1 (99.5–518.3) 134.8 (58.1–312.5) 127.6 (65.4–248.8) 183.9 (100.4–336.7) NS
ELBW 244.4 (104.2–573.1) 250.4 (114.3–548.6) 290.9 (130.5–648.3) 244.5 (107.0–558.5) NS
p-value 0.05 0.01 0.02 0.01 –
OPN [ng/mgCr]
LBW 897.7 (518.9–1553.1) 764.8 (366.9–1593.8) 614.2 (212.3–1776.7) 581.7 (167.6–2018.6) NS
VLBW 1754.8 (787.8–3908.8) 1223.6 (524.1–2856.5) 1159.0 (621.5–2161.5) 1641.9 (976.0–2762.2) NS
ELBW 2274.4 (1115.5–4637.4) 1815.2 (956.4–3445.1) 2611.5 (1087.5–6271.6) 2260.8 (983.9–5194.7) NS
p-value 0.01 0.01 0.01 0.003 –
DOL – days of life; LBW – low body weight; VLBW – very low body weight; ELBW – extremely low body weight; OPN – osteopontin; uOPN – urine osteopontin.
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Table 5. Geometric mean and CI50% of hKIM1 values calculated from data collected in 4 weekly intervals in the study groups; p-values were computed for 
the Jonckheere–Terpstra test for ordered alternatives
Variable 4–7 DOL 8–14 DOL 15–21 DOL 22–28 DOL p-value
Females
hKIM1 [pg/mL]
LBW 74.6 (41.9–132.6) 130.4 (73.1–232.7) 88.8 (43.8–180.0) 69.6 (33.3–145.4) NS
VLBW 73.6 (39.1–138.6) 84.3 (41.6–170.7) 112.4 (59.8–211.1) 115.3 (58.0–229.0) 0.05
ELBW 74.9 (23.9–234.5) 90.3 (41.3–197.6) 173.6 (92.8–324.5) 160.0 (71.6–357.5) NS
p-value NS NS 0.02 0.05 –
hKIM1 [pg/mgCr]
LBW 471.0 (279.0–795.1) 882.5 (489.8–1590.3) 658.7 (367.5–1180.7) 613.8 (337.1–1117.7) NS
VLBW 679.0 (358.8–1285.0) 692.8 (325.2–1476.1) 912.9 (489.7–1701.7) 964.0 (466.6–1991.6) 0.05
ELBW 776.9 (186.9–3230.1) 774.5 (311.0–1928.7) 1347.5 (704.1–2578.8) 1124.2 (562.6–2246.4) NS
p-value NS NS 0.01 0.03 –
Males
hKIM1 [pg/mL]
LBW 75.5 (32.9–173.3) 126.7 (60.7–264.4) 113.6 (59.1–218.6) 89.7 (49.3–163.4) NS
VLBW 88.6 (42.7–183.5) 91.4 (46.3–180.3) 167.8 (92.2–305.3) 115.6 (59.0–226.7) NS
ELBW 82.5 (41.1–165.8) 254.6 (166.0–390.4) 252.0 (151.3–419.8) 161.1 (80.5–322.4) NS
p-value NS NS 0.02 0.01 –
hKIM1 [pg/mgCr]
LBW 513.0 (230.7–1141.0) 995.7 (481.4–2059.1) 815.8 (402.8–1652.6) 619.1 (342.9–1117.9) NS
VLBW 710.4 (321.6–1569.1) 802.6 (403.4–1596.7) 1536.3 (852.8–2767.7) 1031.0 (572.3–1857.4) NS
ELBW 719.7 (354.6–1460.9) 1862.4 (1215.6–2853.2) 2369.4 (1338.3–4194.9) 1390.4 (743.3–2600.5) NS
p-value NS NS 0.01 0.03 –
DOL – days of life; LBW – low body weight; VLBW – very low body weight; ELBW – extremely low body weight; hKIM1 – human kidney injury molecule 1.
Table 6. Pearson correlation coefficients (p-value) for the mean values of the investigated urine tubular biomarkers 
calculated for each patient from 4 to 28 DOL with reference to BW and GA and between the log-norm and PNA values
Biomarker BW vs mean (log10(marker)) GA vs mean (log10(marker)) DOL vs log10(marker)
Female
NGAL [ng/mL] −0.453 (0.012) −0.403 (0.027) −0.103 (0.011)
NGAL [ng/mgCr] −0.484 (0.007) −0.398 (0.029) −0.086 (0.033)
Male
NGAL [ng/mL] −0.609 (0.000) −0.619 (0.000) −0.198 (0.000)
NGAL [ng/mgCr] −0.437 (0.016) −0.472 (0.008) −0.181 (0.000)
Female
OPN [ng/mL] −0.385 (0.036) −0.327 (NS) −0.021 (NS)
OPN [ng/mgCr] −0.477 (0.008) −0.391 (0.032) 0.002 (NS)
Male
OPN [ng/mL] −0.514 (0.004) −0.414 (0.023) −0.005 (NS)
OPN [ng/mgCr] −0.130 (NS) −0.100 (NS) 0.030 (NS)
Female
hKIM1 [pg/mL] −0.152 (NS) −0.171 (NS) 0.131 (0.002)
hKIM1 [pg/mgCr] −0.270 (NS) −0.238 (NS) 0.130 (0.002)
Male
hKIM1 [pg/mL] −0.084 (NS) −0.045 (NS) 0.118 (0.009)
hKIM1 [pg/mgCr] 0.150 (NS) 0.128 (NS) 0.151 (0.001)
BW – body weight; GA – gestational age; PNA – postnatal age; NGAL – neutrophil gelatinase-associated lipocalin; 
OPN – osteopontin; hKIM1 – human kidney injury molecule 1.
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Table 5 presents the geometric means and CI50% for 
the values of hKIM1 by gender for the 4 time intervals 
in  the  groups of  children studied. As  it  follows from 
the data and the Jonckheere–Terpstra test results for or-
dered alternatives, there is no trend of hKIM1 values with 
respect to PNA (except VLBW females); there is, however, 
a significant trend of higher hKIM1 values and lower BW, 
but only at the 3rd and 4th time intervals. The analysis 
of correlation coefficients of the logarithmic hKIM1 values 
did not demonstrate any correlations with BW, GA or PNA 
(Table 6); similarly, the multivariable linear regression per-
formed for logarithmic marker values did not show BW 
or GA to exert a significant effect on the hKIM1 values; 
only in terms of PNA and gender did the regression dem-
onstrate a significant effect of these factors on the marker 
values, as hKIM1 values were significantly (25–30%) higher 
in boys than in girls (Table 7).
Discussion
There are many urinary markers which are detectable 
in neonates, but in this heterogeneous population no clear 
neonatal reference ranges have been developed. Therefore, 
one of the main objectives of this study was to define ap-
propriate values of uNGAL, uOPN and hKIM1 recorded 
in LBW, VLBW and ELBW infants with uncomplicated 
clinical course and with normal kidney function. More-
over, the majority of studies of modern AKI markers only 
include special neonatal populations, such as newborns 
presenting with post-neonatal asphyxia28 or  requiring 
cardiac surgery.29
Studies dedicated to AKI biomarkers in healthy preterm 
and term neonates are not only very scarce, but the re-
sults of such studies are also highly diverse and sometimes 
quite conflicting.30 To illustrate this fact, it should be men-
tioned that there are reports where the uNGAL values are 
quite comparable with the results obtained in the current 
study,17,25,30,31 while in other studies,2,10,23,32–34 the values 
of  uNGAL (and uNGAL/mgCr10,20,33) are higher than 
in this study. In turn, in the study by Askenazi et al.,34 
the values of uOPN are comparable, yet in a report pub-
lished 5 years later by the same author, the values of uOPN 
and uOPN/mgCr are higher than in the current study.33 
 Finally, in the studies by Askenazi et al.10,34 and Genc et al.35 
addressing the hKIM1 and hKIM1/mgCr levels in preterm 
neonates, the values of these biomarkers are comparable 
to those found in this study, but there are also reports 
which published higher values.36,37 Only in 1 study con-
cerning term infants were the hKIM1 and hKIM1/mgCr 
values lower than the values found in the present study.31 
The  causes of  such disparities can mainly be found 
in the days of life in which the urine samples were collected 
from the newborns for measuring particular biomarkers. 
Only in some studies (by La Manna et al.,2 Huynh et al.,17 
Parravicini et al.,25 and Chi-Nien et al).23 were the days 
of urine collection similar to the timespan used in the pres-
ent study, and they included practically the entire neonatal 
period. In the remaining studies, the concentration values 
of the given biomarkers were determined within a much 
shorter timeframe – most often in the very first 7 days 
of life.10,31–33,35–37
Analyzing the  importance and effect of  gender 
on the values of the markers under discussion, one realizes 
that data from the subject literature are fairly scarce and 
ambiguous. There are reports stating that there is a higher 
level and increased variability of uNGAL in girls,17 as well 
as other papers claiming that there is no significant asso-
ciation with gender.23,25,30 The available literature is quite 
unambiguous in stating that there is no correlation and no 
effect of gender on the values of hKIM1.35–37 In the present 
study, gender exerts a highly significant effect of several 
score percent on the values of the 3 investigated tubular 
markers.
Table 7. Multivariable linear regression for the log-norm data in reference to BW, GA, PNA, and gender. The table presents the change (increase/decrease) 
by a given percent of the marker expressed in the original values when the given parameter is changed by a set point value (negative values denote 
a decrease in the marker value at an increase of the given parameter)





























































BW – body weight; GA – gestational age; PNA – postnatal age; NGAL – neutrophil gelatinase-associated lipocalin; OPN – osteopontin; hKIM1 – human 
kidney injury molecule 1; G – gender. 
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Moreover, in the current literature there are various 
– sometimes discrepant – reports concerning the effect 
of GA, BW and PNA on the concentations of the urinary 
renal markers in question. According to a number of stud-
ies, uNGAL is  inversely correlated with GA1,10,17,38; ad-
ditionally, inverse correlations with BW38 and PNA have 
been demonstrated.17 Furthermore, according to Aske-
nazi et al.,10 uNGAL/mgCr also decreases with increas-
ing GA, and there are detailed reports where uNGAL levels 
declined by 23.1%10 or by 17.8%17 for each week of increas-
ing GA. However, there are also researchers who found no 
association between uNGAL and GA23,25,30,39 and those 
who report no correlation with BW,23,30,39 or PNA.23,27,38 
However, Huynh et al.17 demonstrated that uNGAL levels 
declined by 1.33% for each day of PNA. In the present study, 
all of the uNGAL values in both genders were highly in-
versely correlated with BW and GA. Furthermore, statisti-
cally significant decreasing trends of uNGAL with respect 
to PNA and increasing trends with respect to lower BW 
were found. Moreover, in the linear regression, the above 
factors exerted a significant effect on uNGAL values, as did 
PNA. Gender also plays a significant role, since the values 
of uNGAL in girls were significantly higher.
Reports concerning correlations with uOPN are quite 
scarce, as only Askenazi et al.10 showed that uOPN/mgCr 
decreased with increasing GA and that uOPN declined 
by 34.8% for each week of increasing GA. In the present 
study, most of the uOPN values were inversely correlated 
with BW and GA (which was also confirmed by a statisti-
cally significant increasing trend of uOPN values with 
respect to lower BW); nevertheless, an increase of GA by 
1 week (similarly as is the case with PNA) did not exert 
a significant effect on the values of the marker when it was 
analyzed using linear regression. On the other hand, gen-
der played a significant role, since the uOPN values in boys 
were significantly higher.
In the study by Askenazi et al.,10 hKIM1 and hKIM1/mgCr 
were shown to decrease with increasing GA. The same 
correlation concerning only hKIM1 was found by Sarafi-
dis et al.,31 but this study was performed in term infants. 
Nevertheless, there are studies which proved no correlation 
between hKIM1 and GA35,36; likewise, BW has been re-
ported not to correlate with this marker.35,37 On the other 
hand, in a study that was performed in a population of term 
infants, GA correlated positively with hKIM1.37 The pres-
ent study did not demonstrate any correlation between 
hKIM1 and BW or GA (only in the 3rd and 4th time inter-
vals is there a statistically significant inverse correlation 
between hKIM1 and BW). Postnatal age exerted a weak ef-
fect and gender had a significant effect on the marker value 
in the linear regression, since the hKIM1 values in boys 
were significantly higher.
Glomerular filtration rate in  term (and particularly 
in preterm) infants is very low, and there is a wide distri-
bution of normal SCr values, which vary greatly depend-
ing on  the  level of  prematurity and PNA.40 Depending 
on the degree of the neonate’s prematurity, GFR steadily 
improves during the first months of life. Keeping this obser-
vation in mind, we additionally measured the ranges of SCr 
values and calculated eGFR values in the 3 BW groups of ne-
onates with normal kidney function between 4 and 28 DOL.
We are aware of some limitations of this study, includ-
ing the fact that the number of neonates – particularly 
in the ELBW group – is relatively small, but this issue stems 
from the considerable difficulty in forming a study group 
consisting of numerous, homogeneous and unquestion-
ably healthy neonates without comorbidities. Neverthe-
less, a high number of days (214) in the analyzed ELBW 
children made the authors inclined to treat this group 
as a separate entity. Furthermore, analyzing the diagno-
ses (mostly prematurity and respiratory disorders), MAP 
values and SNAP scale, it may be concluded that the entire 
study population was in generally good clinical condition. 
Additionally, the confounding factors (AG) were also ac-
knowledged in the statistical calculations.
The main advantage of the current study was its scru-
pulous collection of serum samples (every 48–72 h) for 
SCr, as well as urine samples (every 24 h) for urinary re-
nal markers throughout the neonatal period in the LBW, 
VLBW and ELBW infants with normal kidney function, 
which allowed for a detailed background to define ref-
erence weekly ranges for SCr, eGFR and 3 AKI urinary 
tubular markers. Also, to minimize the variability related 
to urinary concentration, the correction with urine cre-
atinine was adopted. However, due to the limited number 
of patients included in the study, there is a future need for 
validation and evaluation of the above data in larger groups 
of neonates to provide the most reliable reference values, 
ideally in multicenter studies.
In summary, the findings of this study demonstrate that 
tubular and glomerular function in preterm neonates dur-
ing the 1st month of life is significantly affected by BW, GA 
and PNA. Furthermore, gender also exerts a significant 
effect on the values of the markers studied: the uNGAL 
values are significantly higher in girls, while uOPN and 
hKIM1 are higher in boys. Secondly, we determined the 
values of 3 urine tubular biomarkers (uNGAL, uOPN and 
hKIM1) recorded in a substantially healthy, preterm popu-
lation of neonates with normal kidney function, along with 
any trends of these values with respect to PNA and BW, 
which should form a solid groundwork for rational in-
terpretation of the results of future clinical trials using 
the same AKI biomarkers in very young children.
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